Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03257761
Recruitment Status : Active, not recruiting
First Posted : August 22, 2017
Last Update Posted : November 24, 2021
National Cancer Institute (NCI)
Van Andel Research Institute
Information provided by (Responsible Party):
University of Southern California

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : March 2, 2021
Estimated Study Completion Date : March 2, 2022